News

Pfizer, BioNTech announce early positive data from an ongoing phase 1/2 study of SARS-COV-2 vaccine

Pfizer and BioNTech SE have announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program.

Read More

Jul 02, 2020

By : Team ABLE

Hetero starts supply of Covifor, its Remdesivir generic drug for COVID-19 treatment

ABLE member company, Hetero Drugs, through its subsidiary Hetero Healthcare Ltd, has started supply initial batch of 20,000 vials of Covifor, the Remdesivir generic version made under license from American company, Gilead Sciences

Read More

Jul 01, 2020

By : Team ABLE

NBRI establishes advanced virology lab for COVID-19 testing at Lucknow

It is a Bio Safety Level (BSL) 3 level facility and has been developed based on the guidelines of the Indian Council Medical Research (ICMR), the World Health Organisation (WHO), and the Ministry of Health and Family Welfare.

Read More

Jul 01, 2020

By : Team ABLE

Eco-friendly Synthesis of Gold Nanoparticles from Antarctic Bacteria for Therapeutic Use

Through a study, NCPOR and GU have established that 20-30-nm-sized spherical-shaped GNPs could be synthesized in a controlled environment.

Read More

Jun 30, 2020

By : Team ABLE

Cipla and Boehringer Ingelheim to co-market three oral anti-diabetic drugs

Cipla and Boehringer Ingelheim have partnered in India to co-market three new oral anti-diabetics drugs Oboravo, Oboravo Met and Tiptengio.

Read More

Jun 30, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights